Replies to post #330893 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Indeed and hence:

but close to completely useless due trial design, endpoint and scoring as well as data presentation differences.

Yet lots of claims that Anavex is much better, which is likely true once taking into account results from the PDD and Rett controlled trials.